Genpact Stock Plummets to New 52-Week Low at $33.15

Genpact has reached a new 52-week low, trading at USD 33.15 as of April 30, 2026. This marks a significant decline for the small-cap company, which operates within the miscellaneous industry. Over the past year, Genpact's performance has been relatively modest, with a return of 5.69%, notably lagging behind the S&P 500's impressive 29.45% gain. Despite the recent price drop, Genpact maintains a market capitalization of USD 6,540 million and exhibits strong management efficiency, reflected in a return on equity of 22.31%. The company also boasts a low debt-to-equity ratio of 0.15, indicating a conservative approach to leverage. Additionally, Genpact has shown healthy long-term growth, with operating profit increasing at an annual rate of 10.73%. The stock's price-to-earnings ratio stands at 12.00, while its price-to-book ratio is 2.57. The dividend yield is notably high at 193.37%, further highlighting the company's commitment to returning value to shareholders. As Genpact navigates this challenging period, its financial metrics suggest a stable foundation for potential recovery.